Johnson & Johnson (J&J) has received approval from the European Commission (EC) for its subcutaneous (SC) Darzalex (daratumumab)-based quadruplet regimen in newly diagnosed multiple myeloma (MM).

At just 27 years old, Moonii was a thriving entrepreneur, running multiple successful businesses and even winning prestigious awards for his achievements.

Yale University held its 17th annual “Mandi Schwartz Marrow Donor Registration Drive” Tuesday, in an effort to save lives and honor of a former hockey player ...

Bill Buryn knows his cancer will kill him one day. After years of chemo treatments and a stem cell transplant, his cancer cells are at a low enough level to say he’s in remission, but it’s only a ...

Just months after learning the girls had 'beat this monster,' family received devastating news of return of the disease ...

A multidisciplinary clinical team led by Professor Bernat Soria from the Institute of Bioengineering at the Miguel Hernández ...

Scientists have discovered a new immunotherapy strategy that reduces cancer recurrence in mouse experimental models. The ...

Progression-free survival improvement and drug costs make zanubrutinib a more cost-effective option in relapsed or refractory chronic lymphocytic leukemia (CLL), new research suggests.

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.